Xth Eurasian Hematology-Oncology Congress

http://www.ehog.net/

 

Precision Oncology in MDS: We Still Don't Know Precise Mechanism of Action of HMA or MDS Pathophysiology, IDH1/2 and DNMT3A Have Positive Impact on Response Rates

11 views
December 13, 2019
0 Comments
Login to view comments. Click here to Login
Hematologic Oncology